These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

45 related articles for article (PubMed ID: 9666634)

  • 1. Platelet serotonin transporter in depressed children and adolescents: 3H-paroxetine platelet binding before and after sertraline.
    Sallee FR; Hilal R; Dougherty D; Beach K; Nesbitt L
    J Am Acad Child Adolesc Psychiatry; 1998 Jul; 37(7):777-84. PubMed ID: 9666634
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet serotonin transporter in children and adolescents with obsessive-compulsive disorder or Tourette's syndrome.
    Sallee FR; Richman H; Beach K; Sethuraman G; Nesbitt L
    J Am Acad Child Adolesc Psychiatry; 1996 Dec; 35(12):1647-56. PubMed ID: 8973072
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of serotonin transporter promoter genotype on platelet serotonin transporter functionality in depressed children and adolescents.
    Nobile M; Begni B; Giorda R; Frigerio A; Marino C; Molteni M; Ferrarese C; Battaglia M
    J Am Acad Child Adolesc Psychiatry; 1999 Nov; 38(11):1396-402. PubMed ID: 10560226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Further studies on platelet serotonin transporter binding in depression.
    Nemeroff CB; Knight DL; Franks J; Craighead WE; Krishnan KR
    Am J Psychiatry; 1994 Nov; 151(11):1623-5. PubMed ID: 7943450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet I1-imidazoline binding sites are elevated in depression but not generalized anxiety disorder.
    Piletz JE; Halaris A; Nelson J; Qu Y; Bari M
    J Psychiatr Res; 1996; 30(3):147-68. PubMed ID: 8884655
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of sertraline on mood and immune status in patients with major depression and HIV illness: an open trial.
    Rabkin JG; Wagner G; Rabkin R
    J Clin Psychiatry; 1994 Oct; 55(10):433-9. PubMed ID: 7961520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sertraline, 1S,4S-N-methyl-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-naphthylamine, a new uptake inhibitor with selectivity for serotonin.
    Koe BK; Weissman A; Welch WM; Browne RG
    J Pharmacol Exp Ther; 1983 Sep; 226(3):686-700. PubMed ID: 6310078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serotonergic markers in platelets of patients with major depression: upregulation of 5-HT2 receptors.
    Hrdina PD; Bakish D; Chudzik J; Ravindran A; Lapierre YD
    J Psychiatry Neurosci; 1995 Jan; 20(1):11-9. PubMed ID: 7865496
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelet imipramine binding in depressed children and adolescents.
    Ambrosini PJ; Metz C; Arora RC; Lee JC; Kregel L; Meltzer HY
    J Am Acad Child Adolesc Psychiatry; 1992 Mar; 31(2):298-305. PubMed ID: 1314256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative study of platelet 3H-paroxetine and 3H-imipramine binding in panic disorder patients and healthy controls.
    Faludi G; Tekes K; Tóthfalusi L
    J Psychiatry Neurosci; 1994 Mar; 19(2):109-13. PubMed ID: 8204562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multicenter open-label sertraline study in adolescent outpatients with major depression.
    Ambrosini PJ; Wagner KD; Biederman J; Glick I; Tan C; Elia J; Hebeler JR; Rabinovich H; Lock J; Geller D
    J Am Acad Child Adolesc Psychiatry; 1999 May; 38(5):566-72. PubMed ID: 10230188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low density and high affinity of platelet [3H]paroxetine binding in women with bulimia nervosa.
    Ekman A; Sundblad-Elverfors C; Landén M; Eriksson T; Eriksson E
    Psychiatry Res; 2006 Jun; 142(2-3):219-23. PubMed ID: 16690136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelet 3H-paroxetine binding in control subjects and depressed patients: relationship to serotonin uptake and age.
    Nankai M; Yamada S; Yoshimoto S; Watanabe A; Mori H; Asai K; Toru M
    Psychiatry Res; 1994 Feb; 51(2):147-55. PubMed ID: 8022949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Binding of [3H]paroxetine to platelets of depressed patients: seasonal differences and effects of diagnostic classification.
    D'Hondt P; Maes M; Leysen JE; Gommeren W; Scharpé S; Cosyns P
    J Affect Disord; 1994 Sep; 32(1):27-35. PubMed ID: 7798464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serotonergic function in major depression and effect of sertraline and paroxetine treatment.
    Stain-Malmgren R; Khoury AE; Aberg-Wistedt A; Tham A
    Int Clin Psychopharmacol; 2001 Mar; 16(2):93-101. PubMed ID: 11236074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelet [3H]imipramine and [3H]paroxetine binding in depressed patients.
    Rosel P; Menchón JM; Vallejo J; Arranz B; Navarro MA; Lirón F; Alvarez P
    J Affect Disord; 1997 Jun; 44(1):79-85. PubMed ID: 9186805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The platelet serotonergic system in depression and following sertraline treatment.
    Butler J; Leonard BE
    Int Clin Psychopharmacol; 1988 Oct; 3(4):343-7. PubMed ID: 3235819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kinetics of the interaction of sertraline with the human platelet plasma membrane 5-hydroxytryptamine carrier.
    Phillips OM; Wood KM; Williams DC
    Eur J Pharmacol; 1988 Feb; 146(2-3):299-306. PubMed ID: 3371401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelet 3H-paroxetine binding in depressed patients.
    D'haenen H; De Waele M; Leysen JE
    Psychiatry Res; 1988 Oct; 26(1):11-7. PubMed ID: 2976947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug interaction potential of fluoxetine, sertraline, and paroxetine in four state psychiatric hospital populations.
    Markowitz JS; Devine CL
    Ther Drug Monit; 1997 Apr; 19(2):244-5. PubMed ID: 9108660
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.